AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids' Therapeutic Indications
29 déc. 2016 09h00 HE
|
AXIM Biotechnologies, Inc
NEW YORK, Dec. 29, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in biotechnology cannabinoid research and development, announced today the addition...